Nephrology Dialysis Transplantation

Papers
(The TQCC of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration311
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA266
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey142
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D113
Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls113
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease101
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)88
High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients83
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice80
Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study80
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis77
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)73
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial69
Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism69
Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?69
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)62
Targeting acute kidney injury in COVID-1961
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study59
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disea56
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone56
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAP55
Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study55
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort54
Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management52
Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players48
The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes47
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis44
Acute kidney injury in patients treated with anti-programmed death receptor-1 for advanced melanoma: a real-life study in a single-centre cohort44
The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury and/or proteinuria44
Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study42
Myostatin and muscle atrophy during chronic kidney disease40
Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa39
Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-1939
Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?38
Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease37
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results36
Urine proteomics for prediction of disease progression in patients with IgA nephropathy35
Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the 35
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?35
High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients35
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases35
How to tackle health literacy problems in chronic kidney disease patients? A systematic review to identify promising intervention targets and strategies34
Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease34
Idiopathic retroperitoneal fibrosis: an update for nephrologists34
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study33
SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, ‘diabetic nephropathy’, IgA nephropathy and podocytopathies with FSGS lesions33
What should European nephrology do with the new CKD-EPI equation?33
Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA32
Metagenomic profiling of gut microbiome in early chronic kidney disease32
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 231
Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors31
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant31
Tissue sodium stores in peritoneal dialysis and hemodialysis patients determined by sodium-23 magnetic resonance imaging31
Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort31
Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis30
Effects of calcitriol and paricalcitol on renal fibrosis in CKD30
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease30
Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion29
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment29
Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis29
Mapping health-related quality of life after kidney transplantation by group comparisons: a systematic review29
Acute kidney injury in patients with COVID-19: an update on the pathophysiology28
The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance28
Genetics-first approach improves diagnostics of ESKD patients <50 years old28
The cholinergic anti-inflammatory pathway in chronic kidney disease—review and vagus nerve stimulation clinical pilot study28
Early versus late acute kidney injury among patients with COVID-19—a multicenter study from Wuhan, China27
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years27
Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study26
Chronic kidney disease, physical activity and cognitive function in older adults—results from the National Health and Nutrition Examination Survey (2011–2014)26
Bleeding risk of haemodialysis and peritoneal dialysis patients26
Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population26
Climate change and nephrology26
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS25
The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes25
Armed conflicts and kidney patients: a consensus statement from the Renal Disaster Relief Task Force of the ERA25
Nutritional status, hyperkalaemia and attainment of energy/protein intake targets in haemodialysis patients following plant-based diets: a longitudinal cohort study25
Distal renal tubular acidosis: ERKNet/ESPN clinical practice points25
Renin–angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease25
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease25
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis24
Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis24
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI24
Assisted peritoneal dialysis and transfer to haemodialysis: a cause-specific analysis with data from the RDPLF23
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation23
Increasing incidence and improved survival in ANCA-associated vasculitis—a Danish nationwide study23
Renal transplant outcomes in amyloidosis23
Effect of hemodiafiltration on measured physical activity: primary results of the HDFIT randomized controlled trial23
Factors associated with sex differences in the risk of kidney stones23
Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches23
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA23
Water intake and progression of chronic kidney disease: the CKD-REIN cohort study22
Patient-reported factors influencing the choice of their kidney replacement treatment modality22
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease22
Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry22
Causal effects of physical activity or sedentary behaviors on kidney function: an integrated population-scale observational analysis and Mendelian randomization study22
International peritoneal dialysis training practices and the risk of peritonitis22
Urinary excretion of epidermal growth factor and rapid loss of kidney function21
Tubulointerstitial nephritis and uveitis syndrome: a systematic review21
Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-1921
Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults21
Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia21
Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment20
Dynapaenia and sarcopaenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?20
Renal denervation: where do we stand and what is the relevance to the nephrologist?20
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study20
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis19
Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study19
Magnesium to prevent kidney disease–associated vascular calcification: crystal clear?19
Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study19
Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis18
The Prepare for Kidney Care Study: prepare for renal dialysis versus responsive management in advanced chronic kidney disease18
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study18
Association of urinary sex steroid hormones with urinary calcium, oxalate and citrate excretion in kidney stone formers18
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis18
COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection18
Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study18
Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in a 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules18
Does kidney transplantation with a standard or expanded criteria donor improve patient survival? Results from a Belgian cohort18
Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine18
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE17
Precision medicine approaches for diabetic kidney disease: opportunities and challenges17
Availability of assisted peritoneal dialysis in Europe: call for increased and equal access17
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage17
Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study17
Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease17
Peripheral neuropathy: an important contributor to physical limitation and morbidity in stages 3 and 4 chronic kidney disease17
COVID-19 vaccination in haemodialysis patients: good things come in threes…17
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials17
Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study16
Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis16
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease16
Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study16
Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study16
IgA nephropathy in adults—treatment standard16
Trends in kidney transplantation rate across Europe: study from the ERA Registry16
Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease16
The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification16
Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study16
Efficacy and safety of combination therapy with sodium–glucose cotransporter 2 inhibitors and renin–angiotensin system blockers in patients with type 2 diabetes: a systematic review and meta-analysis16
Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence?15
Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases15
Results of the European EDITH nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease15
Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions and relation to morbidity15
Lessons learned during the war in Ukraine: a report from the Renal Disaster Relief Task Force of the ERA15
The incidence and prevalence of IgA nephropathy in Europe15
Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review15
Long-term renal survival of paediatric patients with lupus nephritis15
Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors15
Precision medicine in Fabry disease15
Can the assessment of ultrasound lung water in haemodialysis patients be simplified?15
Complement inhibitors for kidney disease15
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis15
Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease15
Tertiary lymphoid tissues: a regional hub for kidney inflammation14
Mechanisms of myostatin and activin A accumulation in chronic kidney disease14
Immune checkpoint inhibitor–associated hypercalcaemia14
DNA methylation profiling identifies epigenetic differences between early versus late stages of diabetic chronic kidney disease14
Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders14
The kidney reabsorption-related magnesium depletion score is associated with increased likelihood of abdominal aortic calcification among US adults14
Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease14
Urinary Dickkopf-3: a new biomarker for CKD progression and mortality14
Prolonged patient survival after implementation of a continuous quality improvement programme empowered by digital transformation in a large dialysis network14
Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice14
Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis14
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups14
Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant14
Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial14
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study14
Real-time prediction of intradialytic hypotension using machine learning and cloud computing infrastructure14
CONVINCE in the context of existing evidence on haemodiafiltration14
Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis14
Pre-kidney transplant unintentional weight loss leads to worse post-kidney transplant outcomes14
Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis14
Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations14
Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in haemodialysis patients: a multicentre study13
The risks associated with percutaneous native kidney biopsies: a prospective study13
An intradialytic non-immersive virtual reality exercise programme: a crossover randomized controlled trial13
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease13
Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy13
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis13
Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting13
Prognostic models for chronic kidney disease: a systematic review and external validation13
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study13
Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 y13
Sepsis-associated acute kidney injury—treatment standard13
The influence of repeated flares in response to therapy and prognosis in lupus nephritis13
Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease13
Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s13
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies13
Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia13
The reasons for a clinical trial on incremental haemodialysis13
Drug prescription in patients with chronic kidney disease: a true challenge13
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy13
Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms—results from the RENINE/PROMs registry13
Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention12
Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects12
Laxative use in patients with advanced chronic kidney disease transitioning to dialysis12
Kidney transplantation in patients with multiple myeloma: narrative analysis and review of the last two decades12
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?12
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives12
Perspectives on mental health among patients receiving dialysis12
Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients—a systematic review and meta-analysis12
Nephrology: achieving sustainability12
Evaluation of severity of delayed graft function in kidney transplant recipients12
Barriers to conservative care from patients’ and nephrologists’ perspectives: the CKD-REIN study12
Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)12
Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study12
Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies12
Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological database12
Assessment of a modified renal angina index for AKI prediction in critically ill adults12
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care12
The basics of phosphate metabolism12
Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis in chronic kidney disease patients12
Validity and reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS®) using computerized adaptive testing in patients with advanced chronic kidney disease11
Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality11
Comparison of the association between six different frailty scales and clinical events in patients on hemodialysis11
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab11
Work status and work ability of patients receiving kidney replacement therapy: results from a European survey11
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges11
Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction11
Haemodiafiltration for all: are we CONVINCEd?11
Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy11
Increased risk of ischaemic heart disease after kidney donation11
Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients11
Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry11
Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure11
Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study11
Patterns of renal osteodystrophy 1 year after kidney transplantation11
Plasma exchange in ANCA-associated vasculitis: the pro position11
Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 202011
Iron deficiency after kidney transplantation11
Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis11
Dialysis withdrawal in The Netherlands between 2000 and 2019: time trends, risk factors and centre variation11
Asystole episodes and bradycardia in patients with end-stage renal disease11
High rates of psychological distress, mental health diagnoses and suicide attempts in people with chronic kidney disease in Ireland11
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease—results from the CADA DIA trial11
Urea levels and cardiovascular disease in patients with chronic kidney disease11
Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS11
Screening of Fabry disease in patients with chronic kidney disease in Japan11
Patient-reported outcome measures for life participation in peritoneal dialysis: a systematic review11
Cardiopulmonary exercise testing in patients with end-stage kidney disease: principles, methodology and clinical applications of the optimal tool for exercise tolerance evaluation11
Sodium intake and progression of chronic kidney disease—has the time finally come to do the impossible: a prospective randomized controlled trial?11
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial11
High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database10
Surgical versus endovascular intervention for vascular access thrombosis: a nationwide observational cohort study10
Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study10
Cardiovascular calcifications in kidney transplant recipients10
The role of complement in glomerulonephritis—are novel therapies ready for prime time?10
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib10
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial10
0.09677791595459